View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by GSI Repository Guide for Authors About the Journal ...................................................................... 1 Post-Acceptance .........................................................................4 Article Type Specificatio ns ....................................................... 2 Costs.............................................................................................5 Preparation of Articles .............................................................. 2 Editorial Policies.........................................................................5 How to Submit ........................................................................... 4 Further Informatio n ...................................................................9 ABOUT THE JOURNAL Aims and Scope Journal Details Psychiatry has suffered tremendously by the limited Editor: translational pipeline. Nobel laureate Julius Axelrod’s Julio Licinio, MD discovery in 1957 of monoamine reuptake by pre-synaptic Deputy Director, Translational Medicine and Head, Mind neurons still forms the basis of contemporary antidepressant and Brain Theme treatment. There is a substantial gap between the explosion of South Australian Health and Medical Research Institute knowledge in neuroscience and conceptually novel treatments for our patients. Strategic Professor of Psychiatry Flinders University in Adelaide, South Australia Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical Editorial office: applications, healthcare and global health. We view Nature Publishing Group, 75 Varick St, 9th Floor, New York translation broadly, as the full spectrum of work that marks NY 10013 the pathway from discovery to global health. The steps of [email protected] translation that are within the scope of Translational Psychiatry include Impact factor: 5.538 (2015 Journal Citation Reports , Thomson (i) fundamental discovery, Reuters) (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) Abstracted in: translation to policy and health care guidelines, (v) PubMed/MEDLINE assessment of health policy and usage, and PubMed Central (vi) global health. Scopus ISI Web of Science All areas of medical research, including – but not restricted to DOAJ – molecular biology, genetics, pharmacology, imaging British Library and epidemiology are welcome as they contribute to Crossref enhance the field of translational psychiatry. Translational Psychiatry invites submissions of original articles and reviews, along with invited editorials and perspectives, all of which fall within the field of translational psychiatry. Rev ised January 20, 2015 1 ARTICLE TYPE SPECIFICATIONS Abstract Tables/ Article Description Word Limit References Figures Abstract: 250 words Unstructured Original Articles abstract Article: 5,000 words Max of 5 Max of 100 Please see ‘Preparation of Articles ’ below for details. excluding abstract and references. Abstract: 250 words Unstructured Max of 6-8 Max of 150 Reviews abstract Article: 6,000 words Correspondence Correspondence contributions must respond to an original research article published in Translational Psychiatry no earlier than six months prior to the proposed letter’s submission. Original authors will have the opportunity to respond to the No abstract Article: 700 words letter, should it be chosen for acceptance. This response will Max of 1 Max of 10 required (900 if no image) be published alongside the correspondence. Correspondence should contain no original or novel data. Contributions should start with a two- or three-sentence paragraph that contains the message of the article without specialized terminology. Joint first authors are not allowed. In consultation with the author, the editor may change the title of a Correspondence. PREPARATION OF ARTICLES Please note that original articles must contain the following also include a Conflict of Interest statement, which is also components. Please see below for further details. included in the text of the manuscript (see Editorial Policy • Cover letter (must include a Conflict of Interest section). statement) • Title page (excluding acknowledgements) Title Page: The title page should bear the title of the paper, • Abstract the full names of all the authors, highest academic degree • Introduction obtained, and their affiliations; also, the name, full postal • Materials (or patients) and Methods address, telephone and fax numbers and e-mail address of • Results the author to whom correspondence and offprint requests • Discussion are to be sent (This information is also asked for on the • Acknowledgements electronic submission site). The title should be brief, • Conflict of Interest informative, of 150 characters or less and should not make a statement or conclusion. The running title should consist of • References not more than 50 letters and spaces. It should be as brief as • Figure legends possible, convey the essential message of the paper and • Tables contain no abbreviations. • Figures Abstract: The Abstract should consist of one, single, Cover Letter: The uploaded cover letter must state the continuous paragraph 150-250 words in length. material is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration. The cover letter must Rev ised January 20, 2015 2 Introduction: The Introduction should assume that the Journal article, up to six authors followed by et al.: reader is knowledgeable in the field and should therefore be Barbosa MDFS, Ngyen QA, Tchernev VT, Ashley JA, Detter as brief as possible but can include a short historical review JC, Blaydes SM et al. Identification of the homologous beige where desirable. and Chediak-Higashi syndrome genes. Nature 1996; 382 : 262-65. Materials/Subjects and Methods: This section should Journal article, e-pub ahead of print: contain sufficient detail, so that all experimental procedures Yolken RH, Torrey EF. Are some cases of psychosis caused can be reproduced, and include references. Methods, by microbial agents? A review of the evidence. Mol however, that have been published in detail elsewhere Psychiatry 2008; e-pub ahead of print 12 February 2008; should not be described in detail. Authors should provide doi:10.1038/mp.2008.5. the name of the manufacturer and their location for any specifically named medical equipment and instruments, and Journal article, in press: all drugs should be identified by their pharmaceutical names, Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider and by their trade name if relevant. L et al. ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Results and Discussion: The Results section should briefly Neuropsychopharmacology (in press). present the experimental data in text, tables or figures. Tables and figures should not be described extensively in the text, Complete book: either. The discussion should focus on the interpretation and Badcock C. Evolutionary Psychology: A Critical Introduction. the significance of the findings with concise objective Polity Press: Cambridge, UK, 2000. comments that describe their relation to other work in the area. It should not repeat information in the results. The Chapter in book: final paragraph should highlight the main conclusion(s), Panksepp J. Affective neuroscience: a conceptual framework and provide some indication of the direction future research for the neurobiological study of emotions. In Strongman K should take. (ed). International Reviews of Emotion Research. Wiley: Chichester, UK, 1991, pp 59–99. Acknowledgements: These should be brief, and should include sources of support including sponsorship (e.g. Abstract : university, charity, commercial organization) and sources of Pasanen J. Epigenetics and bipolar disorder. Am J Med Genet material (e.g. novel drugs) not available commercially. C Semin Med Genet 2003; 123 (Suppl 1): 45 (abstract 678). Conflict of Interest: Authors must declare whether or not Letter to the Editor there are any competing financial interests in relation to the Kyritsis AP, Rao JS. Cloning the differences between two work described. This information must be included at this complex genomes [letter]. Science 1993; 259: 946. stage and will be published as part of the paper. Conflict of interest should be noted in the cover letter and as part of the EndNote users should select The Pharmacogenomics submission process. Please see the Conflict of Interest Journal output style for the correct reference style. documentation in the Editorial Policy section for detailed information. Tables: These should be labeled sequentially and cited within the text. Each table should be presented on its own References: Only papers directly related to the article should page, numbered, and titled. Reference to table footnotes be cited. Exhaustive lists should be avoided. References should be made by means of Arabic numerals. Tables should follow the Vancouver format. In the text, they should should not duplicate the content of the text. They should appear as numbers, and at the end of the paper they should consist of at least two columns; columns should always have be listed (double-spaced) in numerical order corresponding headings. Authors should ensure that the data in the tables to the order of citation in the text. All authors should be are consistent with those cited